Oncology

9 Items

This section focuses on basic, translational, and clinical cancer research, including prevention, diagnosis, treatment, survivorship, and palliative care, with attention to precision medicine, innovative therapies, real‑world evidence, and health equity in cancer care.

Section Editor: Stefania Gori    
IRCCS Ospedale Sacro Cuore Don Calabria | Negrar di Valpolicella (VR), Italy

 

All Items

  • Management of refractory metastatic colorectal cancer: consensus recommendations from Italian oncologists

    Fortunato Ciardiello, Carmine Pinto, Salvatore Siena, Alberto Sobrero, Marianna Morani
    7-12
    DOI: https://doi.org/10.33393/ao.2026.3578

  • Follow-up of breast cancer: why is it necessary to start a Consensus in 2024?

    Stefania Gori, Alberto Zambelli, Catia Angiolini, Antonella Ferro, Fiorenza De Rose, Alessandra Fabi, Giuseppe Azzarello, Giuseppe Bogina, Maurizio Cancian, Matteo Valerio, Michela Cinquini, Fabrizio Nicolis, Giovanni Pappagallo
    10-17
    DOI: https://doi.org/10.33393/ao.2024.2634

  • Brentuximab vedotin in combination with doxorubicin, vinblastine and dacarbazine for first-line treatment of stage IV HL: cost impact on subsequent lines in Italy

    Francesca Fiorentino, Beatrice Canali, Paolo Morelli, Federica Demma
    6-12
    DOI: https://doi.org/10.33393/ao.2023.2486

  • Savings associated with therapeutic appropriateness for patients with relapsed refractory multiple myeloma and high cytogenetic risk diagnosed by FISH test

    Rossella Bitonti, Federica Demma, Massimiliano Rea, Gianluca Furneri
    105-111
    DOI: https://doi.org/10.33393/ao.2022.2447

  • Brentuximab vedotin in adult patients with HL CD30+ at high risk of relapse or progression following ASCT: a cost-analysis in Italy

    Gian Luca Breschi, Federica Demma, Paolo Morelli, Maria De Francesco
    81-87
    DOI: https://doi.org/10.33393/ao.2021.2263

  • The value of obinutuzumab for untreated advanced Follicular Lymphoma: an assessment based on Multicriteria Decision Analysis (MCDA)

    Claudio Jommi, Roberto Ravasio
    78-85
    DOI: https://doi.org/10.33393/abtpn.2019.302

  • Performance indicators for monitoring the integrated care pathway of patients with colorectal cancer: the E.Pic.A. project Performance indicators for colorectal cancer

    Andrea Ricotti, Giovanni Messori Ioli, Mattia Altini, Letizia Bachini, William Balzi, Giovanni Luca Frassineti, Fabrizio Gemmi, Ilaria Massa, Andrea Pierini, Oscar Bertetto, Patrizia Racca
    48-54
    DOI: https://doi.org/10.33393/abtpn.2019.292

  • Key performance indicators for monitoring the integrated care pathway in breast cancer: the E.Pic.A. project

    Mattia Altini, William Balzi, Roberta Maltoni, Fabio Falcini, Flavia Foca, Giovanni Messori Ioli, Andrea Ricotti, Oscar Bertetto, Marinella Mistrangelo, Gianni Amunni, Fabrizio Gemmi, Letizia Bachini, Andrea Silenzi, Roberta Pastorino, Andrea Barbara, Andrea Pierini, Ilaria Massa
    31-38
    DOI: https://doi.org/10.33393/abtpn.2019.291

  • Emostatic-palliative radiotherapy in vescical carcinoma: two case reports Radioterapia palliativa-emostatica nel carcinoma vescicale: due case reports.

    Giovanni Ceccon, Stefano Andreani, Marialuisa Bergamini, Sebastiano Buti, Cristina Dell'Anna, Francesca Ghetti, Stella Gianni, Claudia Grondelli, Elisabetta Lattanzi, Pierluigi Losardo, Moana Manicone, Roberto Rossi, Francesco Salaroli, Nunziata D'Abbiero
    2 - 4
    DOI: https://doi.org/10.33393/abtpn.2019.111